XETRA - Delayed Quote EUR
Amgen Inc. (AMG.DE)
246.20
+4.25
+(1.76%)
As of 12:28:32 PM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 22 | 20 | 29 | 26 |
| Avg. Estimate | 8.04B | 8.84B | 35.09B | 35.91B |
| Low Estimate | 7.71B | 8.54B | 33.79B | 34.48B |
| High Estimate | 8.46B | 9.16B | 35.92B | 37.99B |
| Year Ago Sales | 7.45B | 8.39B | 33.42B | 35.09B |
| Sales Growth (year/est) | 7.95% | 5.35% | 4.99% | 2.33% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| AMG.DE | -- | -- | -- | -- |
| S&P 500 | 7.01% | 4.85% | 8.55% | 14.15% |
Upgrades & Downgrades
| Initiated | Cantor Fitzgerald: Overweight | 4/22/2025 |
| Maintains | UBS: Neutral to Neutral | 4/14/2025 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 4/9/2025 |
| Maintains | B of A Securities: Underperform to Underperform | 3/5/2025 |
| Maintains | Piper Sandler: Overweight to Overweight | 2/10/2025 |
| Maintains | B of A Securities: Underperform to Underperform | 2/6/2025 |
Related Tickers
GIS.DE Gilead Sciences, Inc.
93.15
+0.94%
C43.DE Cosmo Pharmaceuticals N.V.
51.50
0.00%
IDP.DE Biogen Inc.
105.10
+1.50%
4AB.DE AbbVie Inc.
153.40
+1.46%
SNW.DE Sanofi
92.26
+1.25%
BRM.DE Bristol-Myers Squibb Company
41.85
-3.39%
IDP.HM Biogen Inc
105.85
+2.52%
GS71.DE GSK plc
16.27
+1.56%
ZEG.DE AstraZeneca PLC
120.70
+1.81%
6MK.DE Merck & Co., Inc.
70.00
+2.34%